Paratek Pharmaceuticals, Inc. Compensation Agreements
12 Contracts & Agreements
- Non-Employee Director Compensation Policy (Filed With SEC on March 14, 2022)
- Non-Employee Director Compensation Policy (Filed With SEC on March 29, 2021)
- Non-Employee Director Compensation Policy (Filed With SEC on May 11, 2020)
- Non-Employee Director Compensation Policy (Filed With SEC on March 6, 2018)
- PARATEK PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on March 2, 2017)
- PARATEK PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on March 9, 2016)
- Amended and Restated Non-Employee Director Cash Compensation Policy Effective as of January 1, 2015 (Filed With SEC on August 11, 2015)
- TRANSCEPT PHARMACEUTICALS, INC. Fourth Amended and Restated Independent Director Equity Compensation Policy Effective April 10, 2013 (Filed With SEC on May 9, 2013)
- TRANSCEPT PHARMACEUTICALS, INC. Third Amended and Restated Independent Director Equity Compensation Policy Effective January 4, 2013 (Filed With SEC on March 12, 2013)
- TRANSCEPT PHARMACEUTICALS, INC. Second Amended and Restated IndependentDirector Cash Compensation Policy Effective June 2, 2010 (Filed With SEC on March 30, 2011)
- NOVACEA, INC. Amended and Restated Independent Director Cash Compensation Policy (Filed With SEC on May 15, 2007)
- NOVACEA, INC. Amended and Restated Independent Director Cash Compensation Policy (Filed With SEC on April 2, 2007)
